NCT05231746View on ClinicalTrials.gov

A Study of hSTC810 With Advanced/Metastatic Solid Tumors (STCUBE-001)

PHASE1CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

April 18, 2022

Primary Completion Date

February 29, 2024

Study Completion Date

February 29, 2024

Conditions
Advanced Solid Tumor
Interventions
BIOLOGICAL

hSTC810

hSTC810 will be administered as an intravenous infusion (IV)

Trial Locations (5)

10029

Mount Sinai Hospital, New York

77030

MD Anderson Cancer Center, Houston

06511

Yale Cancer Center, New Haven

02841

Korea University Anam Hospital, Seoul

03722

Yonsei University Severance Hospital, Seoul

All Listed Sponsors
lead

STCube, Inc.

INDUSTRY